Contact
Please use this form to send email to PR contact of this press release:
BioVie Submits Investigational New Drug Application for BIV201 for Treating Refractory Ascites due to Liver Cirrhosis
TO:
Please use this form to send email to PR contact of this press release:
BioVie Submits Investigational New Drug Application for BIV201 for Treating Refractory Ascites due to Liver Cirrhosis
TO: